Dive into an integrative approach to Precision Medicine - how our modern capacity to interrogate a disease heterogeneity (from omics and phenotyping) and parallel advances in 'big data' together are driving to transform the practice of traditional medicine to precision medicine. After defining the relevant terminologies and the components of precision medicine, the speaker will walk through the spectrum in precision medicine and how it leads to personalized management of disease, which can impact underwriting approaches, product development and pricing. Diabetes will be used as a specific example. TRACK: Pricing/ Product Development (Underwriting, ULSG, Etc.)